Patient
SITE009-0016
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE009 (AUS) (Dr. Novak)
consented 2025-09-17
Adverse events
3
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 3
Grade 1 Thrombocytopenia — outcome: UNKNOWN; onset 2022-12-11 (study day 267); relationship: NOT RELATED
Grade 4 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-10-09 (study day 204); relationship: not assessed; serious criteria: life-threatening
Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-09-22 (study day 187); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.